2024-03-11 18:39:06 ET
CytomX Therapeutics, Inc. (CTMX)
Q4 2023 Results Conference Call
March 11, 2024 05:00 PM ET
Company Participants
Chris Ogden - Senior Vice President, Finance and Accounting
Sean McCarthy - Chief Executive Officer and Chairman
Conference Call Participants
Joe Catanzaro - Piper Sandler
Malcolm Kuno - JPMorgan
Presentation
Operator
Good day, and thank you for standing by. Welcome to the CytomX Therapeutics Fourth Quarter 2023 Financial Results Conference Call. At this time, all participants are in a listen only-mode. After the speaker's presentation there will be a question-and-answer session. [Operator Instructions] Please be advised that, today's conference is being recorded.
I would now like to turn the conference over to your speaker today, Chris Ogden, Senior Vice President, Finance and Accounting. Please go ahead.
Chris Ogden
Thank you. Good afternoon and thank you for joining us.
Before we begin, I would like to remind everyone that, during this call, we will be making forward-looking statements. Because forward-looking statements relate to the future, they are subject to inherent uncertainties and risks that are difficult to predict and many of which are outside of our control....
Read the full article on Seeking Alpha
For further details see:
CytomX Therapeutics, Inc. (CTMX) Q4 2023 Earnings Call Transcript